BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
154 auth. G. Attard, L. Murphy, N. Clarke, W. Cross, Robert J. Jones, C. Parker, S. Gillessen, A. Cook, C. Brawley, C. Amos, N. Atako, C. Pugh, Michelle M. C. Buckner, S. Chowdhury, Z. Malik, ... J. Russell, C. Gilson, H. Rush, J. Bowen, A. Lydon, I. Pedley, J. O’Sullivan, A. Birtle, J. Gale, N. Srihari, Carys W Thomas, J. Tanguay, J. Wagstaff, P. Das, Emma Gray, Mymoona Alzoueb, O. Parikh, A. Robinson, I. Syndikus, J. Wylie, A. Zarkar, G. Thalmann, J. Bono, D. Dearnaley, M. Mason, D. Gilbert, R. Langley, R. Millman, D. Matheson, M. Sydes, L. Brown, M. Parmar, Nicholas D. James, E. Jones, K. Hyde, H. Glen, S. Needleman, U. McGovern, D. Sheehan, S. Paisey, R. Shaffer, M. Beresford, E. Porfiri, D. Fackrell, Ling-hui Lee, T. Sreenivasan, S. Brock, Simon Brown, A. Bahl, Mike Smith-Howell, C. Woodward, M. Phan, D. Mazhar, K. Narahari, F. Douglas, Ajay Kumar, A. Hamid, A. Ibrahim, D. Muthukumar, M. Simms, J. Worlding, A. Tran, M. Kagzi, C. Pezaro, Virgil Sivoglo, B. Masters, Pek Keng-Koh, C. Manetta, D. McLaren, Nishi Gupta, S. Boussios, H. Taylor, J. Graham, C. Perna, L. Melcher, Warren C. Grant, A. Sabharwal, U. Hofmann, R. Dealey, N. McPhail, R. Brierly, L. Capaldi, N. Sidek, P. Whelan, P. Robson, A. Falconer, S. Rudman, S. Vivekanandan, Vinod Mullessey, M. Vilarino-Varela, V. Khoo, K. Tipples, M. Afshar, P. Brulinski, V. Sangar, C. Peedell, A. Azzabi, P. Hoskin, Viwod Mullassery, S. Sundar, Yakhub Khan, R. Conroy, A. Protheroe, J. Carser, P. Rogers, K. Tarver, S. Gibbs, M. M. Khan, M. Hingorani, S. Crabb, M. Alameddine, N. Bhalla, R. Hughes, J. Logue, D. Leaning, Salil Vengalil, D. Ford, G. Walker, A. Shaheen, Omar Khan, Andrew Chan, I. Ahmed, S. Hilman, I. Sayers, A. Nikapota, D. Bloomfield, T. Porter, J. Joseph, C. Rentsch, R. P. Mestre, E. Roggero, JΓΆrg Beyer, M. Borner, R. Strebel, D. Berthold, D. Engeler, Hubert John, Razvan Popescu, Donat Durr
7 2021
7
🐜
🦁 Metastatic spinal cord compression: a rare but important complication of cancer.
P. Robson
5 2014
5
🦁
🐬 Use of methadone for uncontrolled pain: an alternative dosing regimen.
R. Walmsley, P. Robson, M. Lee
2 2010
2
🐬
🐜 The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool.
13 auth. Anna Olsson-Brown, P. Piskilidis, J. O'Hagan, N. Thorp, P. Robson, H. Innes, H. Wong, S. Cicconi, R. Jackson, T. Kiernan, ... C. Holcombe, S. O'Reilly, C. Palmieri
1 2019
1
🐜
🐜 Palliative radiotherapy for prostate cancer: Outcomes of a weekly schedule of 6 fractions of 5 or 6Gy.
9 auth. S. Tolan, P. Mbanu, R. Walshaw, P. Robson, C. Eswarvee, A. Ibrahim, ... Z. Malik, J. Littler, I. Syndikus
1 2012
1
🐜
🐬 Outcomes of high risk prostate cancer patients treated with radical radiotherapy to prostate, seminal vesicles and pelvic lymph nodes
Jane Dufton, C. Eswar, P. Robson, Z. Malik
0 2017
0
🐬
🦁 Glucocorticoids in palliative medicine: is osteoporosis a problem?
P. Robson, A. Hughes
0 2003
0
🦁
🦁 Opioid dose requirements
P. Robson, A. Hughes
0 2003
0
🦁